Response to "Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients"
Haematologica. 2021 Nov 18. doi: 10.3324/haematol.2021.280310. Online ahead of print.ABSTRACTNot available.PMID:34788990 | DOI:10.3324/haematol.2021.280310
Source: Haematologica - Category: Hematology Authors: Jennifer R Brown Source Type: research
More News: Cardiology | Cardiovascular | Chronic Leukemia | Chronic Lymphocytic Leukemia | Heart | Hematology | Leukemia